Hospital
Ascension Seton
Ascension Seton was paid $1.56M by Medicaid between Sep 2020 and Sep 2024, across 23 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
33Billing provider infoASCENSION SETON
BASTROP, TX 78602
BASTROP, TX 78602
33aNPI1942795133assigned 06/29/2018
33bProvider typeSpecial Hospital
28Total paid$1.56M
24GClaims16,847
24DCodes billed23
24AFirst – last monthSep 2020 – Sep 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 117 | $20K | |
| 2021 | 2,238 | $250K | |
| 2022 | 6,371 | $561K | |
| 2023 | 6,124 | $554K | |
| 2024incomplete | 1,997 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 5,344 | 5,234 | $699K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 1,486 | 1,425 | $597K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.4% | 257 | 245 | $131K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.3% | 3,858 | 1,906 | $52K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.1% | 1,708 | 1,670 | $33K |
| 80053 | Comprehensive metabolic panel | 1.0% | 961 | 881 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 165 | 155 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,320 | 1,215 | $7K |
| 81001 | <1% | 676 | 647 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 137 | 135 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 74 | 70 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 223 | 216 | $1K |
11 more codes
| 87807 | <1% | 135 | $1K | |
| 83735 | <1% | 66 | $1K | |
| 83690 | <1% | 90 | $943.95 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 137 | $893.93 |
| 81025 | <1% | 44 | $442.25 | |
| 87070 | <1% | 64 | $200.61 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 26 | $165.39 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13 | $157.74 |
| 84484 | <1% | 26 | $149.57 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 24 | $103.73 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 13 | $25.07 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, ANDY (PRESIDENT CEO ASCENSION TEXAS)
Parent organizationASCENSION SETON